相关实验视频
Updated: Jan 13, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
曼诺斯衍生品作为抗感染剂
1Department of Nursing, Univeristy Center Varaždin, University North, Jurja Križanića 31b, 42000 Varaždin, Croatia.
基于曼诺斯的糖结合物显示出广泛的抗感染潜力. 这篇评论强调了它们对细菌,病毒,真菌和寄生虫的使用,提供了有前途的治疗策略.
科学领域:
- 碳水化合物化学 碳水化合物化学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 曼诺是一种单糖,在宿主-病原体相互作用中至关重要.
- 它作为开发新型抗感染剂的多功能支架.
- 含有曼诺斯的葡萄糖结合物正在研究治疗应用.
研究的目的:
- 审查基于曼诺斯的糖结合物治疗感染的最新进展.
- 为了掩盖它们对抗细菌,病毒,真菌和寄生虫病原体的活动.
- 评估它们作为临床疗法的潜力.
主要方法:
- 基于曼诺斯的葡萄糖结合物的文献综述.
- 分析它们对各种病原体的机制.
- 在临床前模型中评估它们的疗效.
主要成果:
- 曼诺衍生物抑制细菌的粘附 (例如,大肠杆菌) 和破坏生物膜 (例如, Pseudomonas).
- 含有曼诺斯的纳米粒子和树枝状体对HIV,SARS-CoV-2,埃博拉,HPV和HSV表现出抗病毒活性.
- 装饰着曼诺斯的疫苗和纳米载体显示出对抗真菌和寄生虫感染的潜力.
结论:
- 基于曼诺斯的葡萄糖结合物具有显著的抗菌,抗病毒,抗真菌和抗寄生素特性.
- 这些化合物向病原体粘附,生物膜和病毒进入机制.
- 基于曼诺的结构的进一步优化可能会产生有前途的临床抗感染疗法.
更多相关视频
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
12:06Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines
Published on: November 25, 2017
相关概念视频
Cholinergic Antagonists: Pharmacokinetics
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Combined Effects of Drugs: Synergism
Such synergistic combinations...